84 related articles for article (PubMed ID: 8100238)
1. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.
Sauer D; Allegrini PR; Cosenti A; Pataki A; Amacker H; Fagg GE
J Cereb Blood Flow Metab; 1993 Jul; 13(4):595-602. PubMed ID: 8100238
[TBL] [Abstract][Full Text] [Related]
2. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
3. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
Okada M; Ueda H; Kometani M; Nakao K
Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
6. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats.
Okada M; Fujimura Y; Ueda H; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 Feb; 47(2):115-9. PubMed ID: 9079228
[TBL] [Abstract][Full Text] [Related]
7. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
8. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
[TBL] [Abstract][Full Text] [Related]
10. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
11. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
[TBL] [Abstract][Full Text] [Related]
12. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
[TBL] [Abstract][Full Text] [Related]
13. The competitive NMDA antagonist CGP 40116 permanently reduces brain damage after middle cerebral artery occlusion in rats.
Sauer D; Weber E; Lüönd G; Da Silva F; Allegrini PR
J Cereb Blood Flow Metab; 1995 Jul; 15(4):602-10. PubMed ID: 7790408
[TBL] [Abstract][Full Text] [Related]
14. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
15. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.
Jóźwiak L; Łukawski K; Czuczwar SJ; Sieklucka-Dziuba M
Pol J Pharmacol; 2004; 56(1):59-66. PubMed ID: 15047978
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
17. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex.
Wedzony K; Czyrak A
J Physiol Pharmacol; 1996 Sep; 47(3):525-33. PubMed ID: 8877908
[TBL] [Abstract][Full Text] [Related]
18. Assessment of infarct volume in the mouse brain: correlation of magnetic resonance imaging with morphometry.
Weber E; Allegrini PR; Sauer D
In Vivo; 1993; 7(4):335-8. PubMed ID: 8218976
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: in vivo and in vitro studies.
Maier CM; Sun GH; Kunis DM; Giffard RG; Steinberg GK
J Neurochem; 1995 Aug; 65(2):652-9. PubMed ID: 7616221
[TBL] [Abstract][Full Text] [Related]
20. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
